260 related articles for article (PubMed ID: 9565364)
21. Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1.
Liu L; Ma Y; Zhou H; Wu M
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27618897
[TBL] [Abstract][Full Text] [Related]
22. Secretory expression and purification of recombinant Escherichia coli heat-labile enterotoxin B subunit and its applications on intranasal vaccination of hantavirus.
Cao S; Zhang Y; Liu F; Wang Q; Zhang Q; Liu Q; Li C; Liang M; Li D
Mol Biotechnol; 2009 Feb; 41(2):91-8. PubMed ID: 19089660
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunization.
De Magistris MT; Pizza M; Douce G; Ghiara P; Dougan G; Rappuoli R
Dev Biol Stand; 1998; 92():123-6. PubMed ID: 9554265
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen.
Wilson AD; Robinson A; Irons L; Stokes CR
Vaccine; 1993; 11(2):113-8. PubMed ID: 8382416
[TBL] [Abstract][Full Text] [Related]
25. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.
Douce G; Turcotte C; Cropley I; Roberts M; Pizza M; Domenghini M; Rappuoli R; Dougan G
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1644-8. PubMed ID: 7878032
[TBL] [Abstract][Full Text] [Related]
26. Expression of Escherichia coli Heat-Labile Enterotoxin B Subunit in Centella (Centella asiatica (L.) Urban) via Biolistic Transformation.
Loc NH; Tung NV; Kim PTA; Yang MS
Curr Pharm Biotechnol; 2020; 21(10):973-979. PubMed ID: 32101119
[TBL] [Abstract][Full Text] [Related]
27. Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin.
Guidry JJ; Cárdenas L; Cheng E; Clements JD
Infect Immun; 1997 Dec; 65(12):4943-50. PubMed ID: 9393780
[TBL] [Abstract][Full Text] [Related]
28. Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant.
Wagner B; Hufnagl K; Radauer C; Wagner S; Baier K; Scheiner O; Wiedermann U; Breiteneder H
J Immunol Methods; 2004 Apr; 287(1-2):203-15. PubMed ID: 15099768
[TBL] [Abstract][Full Text] [Related]
29. Development of two novel nontoxic mutants of Escherichia coli heat-labile enterotoxin.
Park EJ; Chang JH; Kim JS; Chung SI; Yum JS
Exp Mol Med; 1999 Jun; 31(2):101-7. PubMed ID: 10410310
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S
Vaccine; 2001 Feb; 19(15-16):2071-9. PubMed ID: 11228379
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
[TBL] [Abstract][Full Text] [Related]
32. Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2.
Hazama M; Mayumi-Aono A; Miyazaki T; Hinuma S; Fujisawa Y
Immunology; 1993 Apr; 78(4):643-9. PubMed ID: 8388365
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
34. Safety and immunogenicity of bacterial and tobacco plant cell line derived recombinant native and mutant Escherichia coli heat-labile toxin in chickens.
Miller T; Fanton M; Nickelson S; Mason H; Webb S
Avian Pathol; 2012 Oct; 41(5):441-9. PubMed ID: 22928883
[TBL] [Abstract][Full Text] [Related]
35. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
[TBL] [Abstract][Full Text] [Related]
36. Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B
Lee CH; Hajishengallis G; Connell TD
J Microbiol Biotechnol; 2017 Apr; 27(4):709-717. PubMed ID: 28144014
[TBL] [Abstract][Full Text] [Related]
37. [Expression and characterization of transcutaneous immunization adjuvant LTB and LTK63].
Chen SY; Yi Y; Guo Y; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):8-11. PubMed ID: 16642208
[TBL] [Abstract][Full Text] [Related]
38. Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin.
de Haan L; Verweij WR; Feil IK; Lijnema TH; Hol WG; Agsteribbe E; Wilschut J
Infect Immun; 1996 Dec; 64(12):5413-6. PubMed ID: 8945598
[TBL] [Abstract][Full Text] [Related]
39. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.
Connell TD
Expert Rev Vaccines; 2007 Oct; 6(5):821-34. PubMed ID: 17931161
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the LTK63 adjuvant effect on cellular immune responses to measles virus nucleoprotein.
Erume J; Partidos CD
Afr Health Sci; 2011 Jun; 11(2):151-7. PubMed ID: 21857843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
